The company has received final approval from the United States Food and Drug Administration (USFDA) to market Betamethasone Dipropionate ointment USP 0.05 per cent, Zydus Cadila said in a statement.
from Top Business News- News18.com
Read The Rest:timesnownews...
from Top Business News- News18.com
Read The Rest:timesnownews...
Zydus Cadila Gets USFDA Nod to Market Ointment for Treating Skin Conditions
Reviewed by Team Exprssnews
on
July 15, 2020
Rating:
No comments: